Trial Profile
Comparison of the effects of Pegagen and G-csf in the chemotherapy induced cytopennia in the breast cancer patients
Status:
Active, no longer recruiting
Phase of Trial:
Phase II
Latest Information Update: 12 Apr 2017
Price :
$35
*
At a glance
- Drugs Pegfilgrastim (Primary)
- Indications Leucopenia
- Focus Adverse reactions; Therapeutic Use
- 12 Apr 2017 New trial record
- 20 Mar 2017 Recruitment complete